CD1B and acute lymphoblastic leukemia: The GSE18497 dataset, the only one available with matched diagnosis-relapse paired samples, reported comparable levels of CD1 gene expression in B-ALL and T-ALL at diagnosis and at relapse (Fig. 1b), supporting the immunological targeting of CD1 molecules at both early and late stages of these malignancies.